Sales: $1.3 billion for personal care products.
Corporate sales: $2.2 billion.
Key Personnel: Ritch Wood, chief executive officer; Ryan Napierski, president, global sales and operations; Mark Lawrence, chief financial officer; Joseph Y. Chang, PhD, chief scientific officer and executive vice president, product development; D. Matthew Dorny, vice president, general counsel and secretary.
Major Products: AgeLOC and Epoch skin care products.
New Products: AgeLOC Me and Youth, AgeLOC LumiSpa, To be launched: ageLOC LumiSpa (Q4 2017).
Comments: AgeLOC is an ageless revenue stream for Nu Skin Enterprises. The skin care brand accounted for 29% of corporate sales and 49% of Nu Skin brand sales last year. The other major brand in the company’s skin care lineup is Epoch, which features botanical ingredients derived from renewable sources. Last year, China accounted for 37% of sales, followed by North Asia (30%), South Asia/Pacific (13%), Americas (13%) and EMEA (7%). In fact, 91% of revenue comes from outside the US. At the end of 2016, Nu Skin had approximately 988,000 people who purchased products directly from the company during the past three months.
After 13 years at the helm, Truman Hunt gave way to Ritch Wood as CEO. Prior to this promotion, Wood had been chief financial officer. In other moves, Ryan Napierski was appointed president. Mark H. Lawrence was appointed chief financial officer, effective March 27. Hunt will continue to serve at Nu Skin, this time as vice chairman of the board.
“Mark brings a wealth of leadership experience and an in-depth knowledge of finance and operations that will provide strength to Nu Skin and our senior management team,” said Wood. “In addition, his extensive experience in leadership positions at multiple publicly traded companies provides Mark a strong foundation to understand and leverage the opportunities ahead for our company. We believe he will play a key role in moving Nu Skin toward our short- and long-term strategic goals.”
This fall, Nu Skin will introduce AgeLOC LumiSpa treatments and device. The company hopes the launch can mirror the success of AgeLOC Me and AgeLOC Youth, which debuted in late 2015 and generated sales of more than $500 million through 2016. According to Nu Skin, AgeLOC Me delivers a customized regimen of powerful anti-aging moisturizers and serums from almost 2,000 possible combinations in a simple-to-use, at-home beauty device.
“With the launch of AgeLOC Me, we’re addressing the convergence of two important trends—the growing consumer demand for personalization as well as the growth in anti-aging skin care and home beauty devices,” said Dr. Joseph Chang, chief scientific officer, Nu Skin Enterprises, Inc. “We’re thrilled to offer such a unique product that provides an individualized experience all within one smart device.”
NuSkin said it the expects ageLOC LumiSpa skin renewal and deep-cleansing device will generate about $100 million in sales.
The launch of AgeLOC Me provided a lift to Q1 2017 results; sales rose 6% to nearly $500 million.
“We are pleased to deliver strong first-quarter results, which demonstrates the progress we made executing on our strategic priorities to increase customer trial and acquisition,” said Ritch Wood, chief executive officer. “Our quarterly results reflect solid growth in Mainland China, South Asia/Pacific and EMEA. Our expanding social selling efforts and the continued rollout of ageLOC Me and ageLOC Youth contributed to our strong revenue during the quarter, positioning us to deliver solid performance for 2017.”